This document defines and describes diabetes insipidus, which is caused by a deficiency of antidiuretic hormone resulting in excessive urine production and thirst. There are two main types: central diabetes insipidus caused by issues with the pituitary gland, and nephrogenic diabetes insipidus caused by kidney problems. Symptoms include producing large volumes of dilute urine and extreme thirst. Diagnosis involves tests showing high serum osmolality and low urine osmolality. Treatment focuses on fluid replacement and vasopressin administration to replace the missing hormone.
This document defines and describes diabetes insipidus, which is caused by a deficiency of antidiuretic hormone resulting in excessive urine production and thirst. There are two main types: central diabetes insipidus caused by issues with the pituitary gland, and nephrogenic diabetes insipidus caused by kidney problems. Symptoms include producing large volumes of dilute urine and extreme thirst. Diagnosis involves tests showing high serum osmolality and low urine osmolality. Treatment focuses on fluid replacement and vasopressin administration to replace the missing hormone.
This document defines and describes diabetes insipidus, which is caused by a deficiency of antidiuretic hormone resulting in excessive urine production and thirst. There are two main types: central diabetes insipidus caused by issues with the pituitary gland, and nephrogenic diabetes insipidus caused by kidney problems. Symptoms include producing large volumes of dilute urine and extreme thirst. Diagnosis involves tests showing high serum osmolality and low urine osmolality. Treatment focuses on fluid replacement and vasopressin administration to replace the missing hormone.
This document defines and describes diabetes insipidus, which is caused by a deficiency of antidiuretic hormone resulting in excessive urine production and thirst. There are two main types: central diabetes insipidus caused by issues with the pituitary gland, and nephrogenic diabetes insipidus caused by kidney problems. Symptoms include producing large volumes of dilute urine and extreme thirst. Diagnosis involves tests showing high serum osmolality and low urine osmolality. Treatment focuses on fluid replacement and vasopressin administration to replace the missing hormone.
Download as PPTX, PDF, TXT or read online from Scribd
Download as pptx, pdf, or txt
You are on page 1of 20
Definition
Diabetes insipidus is a disorder of the posterior lobe of the
pituitary gland characterized by a deficiency of antidiuretic hormone (ADH), or vasopressin.
Great thirst (polydipsia) and large volumes of dilute urine
characterize the disorder. Types of Diabetes insipidus A) Central diabetes insipidus B) Nephrogenic diabetes insipidus Causes Central diabetes insipidus • Head trauma or surgery • Pituitary or hypothalamic tumor • Intracerebral occlusion or infection Nephrogenic diabetes insipidus • Systemic diseases involving the kidney • Multiple myeloma • sickle cell anemia • Polycystic kidney disease • Pyelonephritis • Medications such as lithium Pathophysiology Central diabetes insipidus Loss of vasopressin-producing cells
Causing deficiency in antidiuretic hormone (ADH) synthesis or release
Deficiency in ADH, resulting in an inability to conserve water, leading
to extreme polyuria and polydipsia Nephrogenic diabetes insipidus
• Depression of aldosterone release or inability of the nephrons
to respond to ADH, causing extreme polyuria and polydipsia Signs and symptoms • Polyuria with urine output of 5 to 15 L daily Polydipsia, especially a desire for cold fluids
• Marked dehydration, as evidenced by dry mucous
membranes, dry skin, and weight loss
• Anorexia and epigastric fullness
• Nocturia and related fatigue from interrupted sleep
Diagnostic test
1. High serum osmolality, usually above 300 mOsm/kg of water
Low urine osmolality, usually 50 to 200 mOsm/kg of water
2. low urine-specific gravity of less than 1.005
3. Increased creatinine and blood urea nitrogen (BUN) levels
resulting from dehydration
4. Positive response to water deprivation test: Urine output
decreases and specific gravity increases Protocol (Phase 1): • The test should be initiated at 10 PM at which time serum and urine specimens are collected for the determination of sodium and osmolality. The patient should also be weighed at this time. No oral intake is allowed until the test is terminated. • At 6 AM, the following morning, the patient should be weighed again. Weight should be measured and urine should be collected hourly for measurement of volume and determination of osmolality. • Once urine osmolality becomes stable (a change <30 mOsm/kg for two consecutive hours) specimens are collected for serum sodium, osmolality, and ADH levels. Protocol (Phase 2): • Five units of aqueous vasopressin (ADH) is given subcutaneously, and urine osmolality is measured one hour later. The test can then be terminated. Goals of management The objectives of therapy are : (1)To replace ADH (which is usually a long-term therapeutic program) (2) To ensure adequate fluid replacement (3) To identify and correct the underlying cause Treatments • Replacement vasopressin therapy with intranasal or I.V. desmopressin acetate • Correction of dehydration and electrolyte imbalances • Administration of thiazide diuretics to deplete sodium and increase renal water reabsorption • Restriction of salt and protein intake Nursing management Nursing Assessment • Polyuria of 4 to 24 L per day • Polydipsia • Dehydration • Decreased skin turgor, dry mucous membranes • Inability to concentrate urine • A low urinary specific gravity: 1.006 or less • Fatigue • Muscle pain and weakness • Headache • Postural hypotension that may progress to vascular collapse without rehydration • Tachycardia Nursing Interventions • Monitor vital signs and neurological and cardiovascular status.
• Monitor electrolyte values and for signs of dehydration.
• Monitor intake and output, weight, and specific gravity of urine.
• Maintain the intake of adequate fluids, and monitor for signs of
dehydration. • Instruct the client to avoid foods or liquids that produce diuresis.
• Administer vasopressin or desmopressin acetate as prescribed ,
these are used when the ADH deficiency is severe or chronic. may be administered by injection, intra nasally, or orally).
• Instruct the client to wear a Medic-Alert bracelet.